Rothschild Investment LLC’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.93K Buy
62
+29
+88% +$1.49K ﹤0.01% 2585
2026
Q1
$1.96K Hold
33
﹤0.01% 2572
2025
Q4
$2.04K Buy
33
+18
+120% +$1.1K ﹤0.01% 2362
2025
Q3
$936 Sell
15
-45
-75% -$3.13K ﹤0.01% 2607
2025
Q2
$4.79K Sell
60
-10
-14% -$836 ﹤0.01% 1532
2025
Q1
$6.02K Buy
70
+20
+40% +$1.64K ﹤0.01% 1353
2024
Q4
$3.9K Buy
50
+10
+25% +$776 ﹤0.01% 1439
2024
Q3
$2.88K Buy
40
+20
+100% +$1.42K ﹤0.01% 1538
2024
Q2
$1.38K Buy
20
+15
+300% +$1.02K ﹤0.01% 1516
2024
Q1
$363 Buy
+5
New +$334 ﹤0.01% 1474

Other funds holding PBH

Rothschild Investment LLC's PBH Position: Q2 2026 in Review

Rothschild Investment LLC increased its Prestige Consumer Healthcare (PBH) stake by 88% in Q2 2026, buying an estimated $1.49K and bringing the position to 62 shares worth $2.93K. The position accounts for ﹤0.01% of the portfolio, ranked #2585.

Rothschild Investment LLC first reported a position in PBH in Q1 2024 and has held it in 10 quarters since. The position peaked at $6.02K in Q1 2025. 319 funds tracked by Wall St. Rank hold PBH as of Q2 2026.

  • Rothschild Investment LLC held 62 shares of Prestige Consumer Healthcare worth $2.93K as of Q2 2026.
  • Rothschild Investment LLC bought 29 Prestige Consumer Healthcare shares in Q2 2026, an estimated $1.49K.
  • Prestige Consumer Healthcare made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #2585 holding.
  • Rothschild Investment LLC first reported a position in Prestige Consumer Healthcare in Q1 2024 and has held it in 10 quarters since.
  • Rothschild Investment LLC's Prestige Consumer Healthcare position peaked at $6.02K in Q1 2025.
  • 319 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.